Jennifer Martin

Reducing Inappropriate Polypharmacy

Ian Scott, Sarah N. Hilmer, Emily Reeve et al. · JAMA Internal Medicine · 2015 · 1.4K citations · Full text

Drug Safety, Harm Reduction, Health Sciences +14

Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats

J. Andrew Pospisilik, Jennifer Martin, Timothy Doty et al. · Diabetes · 2003 · 334 citations · Full text

Therapeutic drug monitoring of antimicrobials

Jason A. Roberts, Ross Norris, David L. Paterson et al. · British Journal of Clinical Pharmacology · 2011 · 306 citations · Full text

Systematic Tdm Programme, Antimicrobial Chemotherapy, Drug Resistance +17

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

Veronique Chachay, Graeme A. Macdonald, Jennifer Martin et al. · Clinical Gastroenterology and Hepatology · 2014 · 281 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study

Paola Nicoletti, Guruprasad P. Aithal, Einar S. Björnsson et al. · Gastroenterology · 2016 · 215 citations · Full text